EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma

Cornelius M Funk, Anna C Ehlers, Martin F Orth, Karim Aljakouch, Jing Li, Tilman Lb Hölting, Rainer Will, Florian H Geyer, A Katharina Ceranski, Franziska Willis, Endrit Vinca, Shunya Ohmura und 23 weitere

Journal of Clinical Investigation · 15.12.2025 · 135 (24)

DOI: 10.1172/jci187627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 16.10.2025. Verfasst von Cornelius M Funk und 34 weiteren Autor:innen. Beteiligte Einrichtung: German Cancer Research Center (DKFZ) Heidelberg, Division of Translational Pediatric Sarcoma Research, Heidelberg, Germany. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Cyclin-Dependent Kinase 6, Cyclin-Dependent Kinase 4, Chromosomes, Human, Pair 8. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Cancer Aid, Matthias-Lackas foundation, Dr. Leopold und Carmen Ellinger foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chromosome 8 (chr8) gains are common in cancer, but their contribution to tumor heterogeneity is largely unexplored. Ewing sarcoma (EwS) is defined by FET::ETS fusions with few other recurrent mutations to explain clinical diversity. In EwS, chr8 gains are the second most frequent alteration, making it an ideal model to study the relevance of chr8 gains in an otherwise silent genomic context. We report that chr8 gain–driven expression patterns correlate with poor overall survival of patients with EwS. This effect is mainly mediated by increased expression of the translation initiation factor binding protein 4E-BP1, encoded by EIF4EBP1 on chr8. Among all chr8-encoded genes, EIF4EBP1 expression showed the strongest association with poor survival and correlated with chr8 gains in EwS tumors. Similar findings emerged across multiple cancer entities in The Cancer Genome Atlas. Multiomics profiling revealed that 4E-BP1 orchestrates a pro-proliferative proteomic network. Silencing 4E-BP1 reduced proliferation, clonogenicity, spheroidal growth in vitro, and tumor growth in vivo. Drug screens demonstrated that high 4E-BP1 expression sensitizes EwS to pharmacological CDK4/6-inhibition. Chr8 gains and elevated 4E-BP1 emerge as prognostic biomarkers in EwS, with poor outcomes driven by 4E-BP1–mediated pro-proliferative networks that sensitize tumors to CDK4/6 inhibitors. Testing for chr8 gains may enhance risk stratification and therapy in EwS and other cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, EwingCyclin-Dependent Kinase 6Cyclin-Dependent Kinase 4Chromosomes, Human, Pair 8Adaptor Proteins, Signal TransducingGene Expression Regulation, NeoplasticNeoplasm ProteinsBone NeoplasmsHumansCell Cycle ProteinsAnimalsMiceCell Line, TumorFemaleMale

Stichwörter der Autor:innen

CancerGenetic variationGeneticsMouse modelsOncology

Substanzen

Cyclin-Dependent Kinase 6Cell Cycle ProteinsCyclin-Dependent Kinase 4CDK6 protein, humanCDK4 protein, humanEIF4EBP1 protein, humanAdaptor Proteins, Signal TransducingNeoplasm Proteins

Autor:innen und Institutionen

  • German Cancer Research Center (DKFZ) Heidelberg, Division of Translational Pediatric Sarcoma Research, Heidelberg, Germany.
  • Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.
  • Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, Ludwig Maximilian University (LMU) Munich, Munich, Germany.
  • DKFZ Heidelberg, Division of Proteomics of Stem Cells and Cancer, Heidelberg, Germany.
  • Medical Faculty, Heidelberg University, Heidelberg, Germany.

Förderung

  • German Cancer Aid
  • Matthias-Lackas foundation
  • Dr. Leopold und Carmen Ellinger foundation
  • Gert & Susanna Mayer foundation
  • Deutsche Forschungsgemeinschaft
  • Dr. Rolf M. Schwiete foundation
  • SMARCB1 association
  • Ministry of Education and Research

Zitieren

APA

Funk, C. M., Ehlers, A. C., Orth, M. F., Aljakouch, K., Li, J., Hölting, T. L., Will, R., Geyer, F. H., Ceranski, A. K., Willis, F., Vinca, E., Ohmura, S., Imle, R., Siebenlist, J., Yershova, A., Knott, M. M., Zahnow, F., Sastre, A., Alonso, J., …, & Musa, J. (2025). High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma. Journal of Clinical Investigation, 135(24). https://doi.org/10.1172/jci187627

Vancouver

Funk CM, Ehlers AC, Orth MF, Aljakouch K, Li J, Hölting TL, et al. High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma. Journal of Clinical Investigation. 2025;135(24). doi:10.1172/jci187627

BibTeX
@article{Funk2025,
  author = {Funk, Cornelius M and Ehlers, Anna C and Orth, Martin F and Aljakouch, Karim and Li, Jing and Hölting, Tilman Lb and Will, Rainer and Geyer, Florian H and Ceranski, A Katharina and Willis, Franziska and Vinca, Endrit and Ohmura, Shunya and Imle, Roland and Siebenlist, Jana and Yershova, Angelina and Knott, Maximilian Ml and Zahnow, Felina and Sastre, Ana and Alonso, Javier and Sahm, Felix and Peterziel, Heike and Loboda, Anna and Schneider, Martin and Banito, Ana and Leprivier, Gabriel and Hartmann, Wolfgang and Dirksen, Uta and Witt, Olaf and Oehme, Ina and Pfister, Stefan M and Romero-Pérez, Laura and Krijgsveld, Jeroen and Cidre-Aranaz, Florencia and Grünewald, Thomas Gp and Musa, Julian},
  title = {High 4E-BP1 expression associates with chromosome 8 gain and CDK4/6 sensitivity in Ewing sarcoma},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {24},
  doi = {10.1172/jci187627}
}
Kostenlos starten →